INS and type 2 diabetes mellitus: This includes more macrophage infiltration and increased synthesis of pro-inflammatory cytokines like TNF-α and IL-6, hence disrupting insulin signaling and driving insulin resistance.[5] Systemic markers – that is, C-reactive protein (CRP) – indicate increased T2D, hence show general inflammation.